The Nightly Use of Sodium Oxybate Is Associated with a Reduction in Nocturnal Sleep Disruption: A Double-Blind, Placebo-Controlled Study in Patients with Narcolepsy

Podobne knjige/članki

• RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates
  od: Asim Roy, et al.
  Izdano: (2024-12-01)
• Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing
  od: Feldman, Neil T.
  Izdano: (2009)
• Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
  od: Bogan, Richard K, et al.
  Izdano: (2020)
• Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy
  od: Husain, Aatif M., et al.
  Izdano: (2020)
• Corrigendum to: Efficacy and Safety of Calcium, Magnesium, Potassium, and Sodium Oxybates (Lower-Sodium Oxybate [LXB]; JZP-258) in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Narcolepsy With Cataplexy
  od: Bogan, Richard K, et al.
  Izdano: (2021)